Bruker - BRKR Stock Forecast, Price & News

3 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Bruker in the last twelve months. There are currently 1 sell rating, 1 hold rating and 1 buy rating for the stock. The consensus among Wall Street equities research analysts is that investors should "hold" BRKR shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in BRKR, but not buy additional shares or sell existing shares.
View BRKR analyst ratings or view top-rated stocks.

3 analysts have issued 1 year target prices for Bruker's shares. Their BRKR share price forecasts range from $60.00 to $90.00. On average, they expect the company's stock price to reach $78.33 in the next twelve months. This suggests a possible upside of 26.0% from the stock's current price.
View analysts price targets for BRKR or view top-rated stocks among Wall Street analysts.

Bruker's stock was trading at $83.91 at the beginning of the year. Since then, BRKR shares have decreased by 25.9% and is now trading at $62.16.
View the best growth stocks for 2022 here.

Bruker is scheduled to release its next quarterly earnings announcement on Monday, November 7th 2022.
View our BRKR earnings forecast.

Bruker Co. (NASDAQ:BRKR) announced its quarterly earnings data on Wednesday, August, 3rd. The medical research company reported $0.45 EPS for the quarter, hitting the consensus estimate of $0.45. Bruker had a net margin of 11.06% and a trailing twelve-month return on equity of 31.36%. During the same quarter in the previous year, the company earned $0.44 EPS.

Bruker announced a quarterly dividend on Monday, May 16th. Shareholders of record on Wednesday, June 1st will be paid a dividend of $0.05 per share on Friday, June 17th. This represents a $0.20 annualized dividend and a yield of 0.32%. The ex-dividend date is Tuesday, May 31st.
Read our dividend analysis for BRKR.

Bruker (NASDAQ:BRKR) pays an annual dividend of $0.20 per share and currently has a dividend yield of 0.32%. The company does not yet have a strong track record of dividend growth. The dividend payout ratio is 11.05%. This payout ratio is at a healthy, sustainable level, below 75%. Based on earnings estimates, BRKR will have a dividend payout ratio of 7.78% next year. This indicates that the company will be able to sustain or increase its dividend.
Read our dividend analysis for BRKR.

Bruker updated its FY22 earnings guidance on Wednesday, August, 3rd. The company provided earnings per share guidance of $2.29-2.33 for the period, compared to the consensus earnings per share estimate of $2.29. The company issued revenue guidance of ~$2.48-2.53 billion, compared to the consensus revenue estimate of $2.55 billion.

126 employees have rated Bruker Chief Executive Officer Frank H. Laukien on Glassdoor.com. Frank H. Laukien has an approval rating of 54% among the company's employees. This puts Frank H. Laukien in the bottom 25% of approval ratings compared to other CEOs of publicly-traded companies. 79.0% of employees surveyed would recommend working at Bruker to a friend.

Based on aggregate information from My MarketBeat watchlists, some companies that other Bruker investors own include AbbVie (ABBV), CVS Health (CVS), Micron Technology (MU), Cisco Systems (CSCO), Intel (INTC), Alibaba Group (BABA), Walt Disney (DIS), Applied Materials (AMAT), Bank of America (BAC) and Bristol-Myers Squibb (BMY).

Bruker trades on the NASDAQ under the ticker symbol "BRKR."

Bruker's stock is owned by a number of retail and institutional investors. Top institutional shareholders include TD Asset Management Inc. (1.11%), Brown Advisory Inc. (0.93%), Candriam S.C.A. (0.28%), Sector Gamma AS (0.17%), Ceredex Value Advisors LLC (0.10%) and Retirement Systems of Alabama (0.09%). Insiders that own company stock include Burkhard Prause, Cynthia M Friend, Frank H Laukien, Marc A Kastner and Mark Munch.
View institutional ownership trends.

Shares of BRKR stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

One share of BRKR stock can currently be purchased for approximately $62.16.

Bruker (NASDAQ:BRKR) has a market capitalization of $9.28 billion and generates $2.42 billion in revenue each year. The medical research company earns $277.10 million in net income (profit) each year or $1.81 on an earnings per share basis.

Bruker employs 7,765 workers across the globe.

Bruker was founded in 1960.

Bruker's mailing address is 40 Manning Road, Billerica MA, 01821. The official website for the company is www.bruker.com. The medical research company can be reached via phone at (978) 663-3660, via email at investor.relations@bruker.com, or via fax at 978-663-5585.